头颈部鳞癌(head and neck squamous cell carcinoma, HNSCC) 是头颈部肿瘤的常见类型,
其治疗水平有待提高. 作为一种具有高度免疫缺陷的肿瘤, HNSCC 主要机制包括免疫耐受的 …

The predominant type of head and neck cancer is head and neck squamous cell carcinoma
(HNSCC), which needs more effective treatment. As a highly immunosuppressive …

目前头颈部鳞状细胞癌(HNSCC) 的免疫治疗是头颈部肿瘤治疗的重要研究领域.
以程序性死亡蛋白-1 (PD-1)/程序性死亡配体(PD-L1) 为靶点的药物在包括HNSCC …

Head and neck squamous cell carcinoma (HNSCC) is a frequent tumour arising from
multiple anatomical subsites in the head and neck region. The treatment for early-stage …

Abstract Background Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and
activate the immune system to eliminate cancer cells. Head and neck squamous cell …

Three randomized phase III trials have now conclusively proven that exposure to a PD-1
inhibitor prolongs survival in recurrent/metastatic (R/M) HNSCC, and it is clear that such …

Abstract Purpose of Review Discussion of current strategies targeting the immune system
related to solid tumors with emphasis on head and neck squamous cell carcinoma …

Objective: Provide a narrative review of the literature describing immunological concepts
and novel approaches in the treatment of head and neck squamous cell carcinoma …

Anticancer immunity modulation is the current standpoint of research and has revolutionized
the standard of care of platinum refractory recurrent/metastatic head and neck carcinoma of …

Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer globally,
originating from the epithelial surface of the upper aerodigestive tract from the lips to the …